Showing results (281-290 of 308) with videos related to
Sort By:
Pageof 31
Cancer Discovery|December 3, 2017
Genomic Landscape of Cell-Free DNA in Patients with Colorectal CancerJohn H Strickler, Jonathan M Loree, Leanne G Ahronian, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 22, 2018
Anaplastic Lymphoma Kinase Mutation (ALK F1174C) in Small Cell Carcinoma of the Prostate and Molecular Response to AlectinibBenedito A Carneiro, Sahithi Pamarthy, Ami N Shah, et al.Orvosi Hetilap|June 23, 2001
[Analgesics-induced chronic renal failure in patients on dialysis therapy in Hungary]I Pintér, J Mátyus, Z Czégány, et al.Cancer|January 9, 2019
Circulating tumor DNA alterations in patients with metastatic castration-resistant prostate cancerGuru Sonpavde, Neeraj Agarwal, Gregory Russell Pond, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 26, 2018
Validation of a Plasma-Based Comprehensive Cancer Genotyping Assay Utilizing Orthogonal Tissue- and Plasma-Based MethodologiesJustin I Odegaard, John J Vincent, Stefanie Mortimer, et al.Breast Cancer Research : BCR|April 22, 2024
NSABP FB-10: a phase Ib/II trial evaluating ado-trastuzumab emtansine (T-DM1) with neratinib in women with metastatic HER2-positive breast cancerSamuel A Jacobs, Ying Wang, Jame Abraham, et al.JCO Precision Oncology|June 7, 2021
Serial Monitoring of Circulating Tumor DNA by Next-Generation Gene Sequencing as a Biomarker of Response and Survival in Patients With Advanced NSCLC Receiving Pembrolizumab-Based TherapyJeffrey C Thompson, Erica L Carpenter, Benjamin A Silva, et al.JCO Precision Oncology|August 21, 2018
Heterogeneity and Coexistence of T790M and T790 Wild-Type Resistant Subclones Drive Mixed Response to Third-Generation Epidermal Growth Factor Receptor Inhibitors in Lung CancerZofia Piotrowska, Mehlika Hazar-Rethinam, Coleen Rizzo, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 20, 2018
Identification of Incidental Germline Mutations in Patients With Advanced Solid Tumors Who Underwent Cell-Free Circulating Tumor DNA SequencingThomas P Slavin, Kimberly C Banks, Darya Chudova, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 23, 2020
MET Alterations Are a Recurring and Actionable Resistance Mechanism in ALK-Positive Lung CancerIbiayi Dagogo-Jack, Satoshi Yoda, Jochen K Lennerz, et al.Pageof 31